The United States leads the global R&D budget for health and medical sciences, maintaining a dominant position with minimal growth at 0.38% YoY. Germany, Japan, and the United Kingdom follow, showing significant growth, particularly Japan with an 18.05% increase. In Europe, Italy and Poland exhibited the most notable expansion. Conversely, countries like Sweden and Mexico experienced negative growth. Emerging economies, although initially minor contributors, show varied but promising potential with Hungary, Cyprus, and Malta showing upward trends.
Future trends to watch include increasing investments in Asia-Pacific regions, driven by technological advancements and growing healthcare needs. The continuous rise in artificial intelligence applications and personalized medicine will likely influence budget allocations. Additionally, geopolitical factors and economic shifts may impact funding distribution globally.
Top countries in R&D Budget for Health and Medical Sciences Share by Country (Million US Dollars PPP, Constant)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 50.37 | 2023 | +3.43% | +0.38% | View data |
| 2 | 2 Germany | 10.05 | 2023 | +3.66% | +5.01% | View data |
| 3 | 3 Japan | 5.71 | 2023 | +7.27% | +18.05% | View data |
| 4 | 4 United Kingdom | 5.08 | 2023 | +2.08% | +2.59% | View data |
| 5 | 5 France | 4.85 | 2023 | -2.93% | +6.65% | View data |
| 6 | 6 South Korea | 3.47 | 2023 | +3.46% | +7.66% | View data |
| 7 | 7 Netherlands | 2.89 | 2023 | +2.81% | +5.85% | View data |
| 8 | 8 Spain | 2.78 | 2023 | +1.88% | +2.82% | View data |
| 9 | 9 Taiwan | 2.73 | 2023 | +3.59% | +4.21% | View data |
| 10 | 10 Italy | 2.53 | 2023 | -0.61% | +10.45% | View data |
